Diets rich in polyphenols were linked to reduced prevalence of hypertension up to 36%.
Dietary intake of polyphenols may reduce risk of hypertension in elderly subjects, according to new research published in the May 2011 issue of the journal Nutrition, Metabolism, and Cardiovascular Diseases.
Researchers from several Spanish universities assigned 589 subjects to a food frequency questionnaire for 136 food items. Subjects were over 55 years old, mostly overweight, and related to various cardiovascular risk factors (33% diabetics, 81% hypertensive, 16% active smokers, etc.).
Total urinary excretion of phenols was measured as an indicator of total polyphenol intake and blood pressure. Polyphenols were categorized into one of three groups: fruits and vegetables, coffee, or wine.
One hundred grams of fruits and vegetables was found to provide more polyphenols than 100 mL of coffee or 100 mL of wine. A significant positive association was observed between total excreted polyphenols and intake of these food groups.
Researchers found that higher urinary counts of polyphenols were associated with greatly reduced cardiovascular risks. Subjects in the highest quartile of total urinary polyphenols actually showed a 36% reduced risk of hypertension, compared to the lowest quartile.
The researchers concluded that “a high intake of polyphenol-rich diet may help to decrease blood pressure in elderly hypertensive populations in order to lower their cardiovascular risk. However, the observation that systolic and diastolic BP decrease when TPE increases needs to be confirmed in further intervention studies. A longer follow-up of the [trial] will eventually provide the evidence to confirm our results.”
Funding for the study was provided by the Spanish Ministry of Science and Innovatio and the Instituto de Salud Carlos III.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.